Patient blood management in elective total hip- And knee-replacement surgery (Part 2): A randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl

Anesthesiology

Volumn 120, Issue 4, 2014, Pages 852-860

  So Osman, Cynthia ^a   Nelissen, Rob G H H ^b   Van Gemert, Ankie W M M Koopman ^c   Kluyver, Ewoud ^d   Pöll, Ruud G ^e   Onstenk, Ron ^f   Van Hilten, Joost A ^a   Jansen Werkhoven, Thekla M ^b   Van Den Hout, Wilbert B ^b   Brand, Ronald ^b   Brand, Anneke ^a,b  

^a Department Center of Clinical Transfusion Research Sanquin Blood Supply ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^d SLOTERVAART HOSPITAL   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f GROENE HART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

AGED; ARTICLE; AUTOTRANSFUSION UNIT; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD TRANSFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIP ARTHROPLASTY; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLICY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUCTION DRAIN; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; ECONOMICS; EQUIPMENT; KNEE ARTHROPLASTY; METHODOLOGY; NETHERLANDS; POSTOPERATIVE CARE; PROSPECTIVE STUDY; STATISTICS; WOUND DRAINAGE;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRAINAGE; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; MALE; NETHERLANDS; OPERATIVE BLOOD SALVAGE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 84901758398     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000135     Document Type: Article

References (25)

1. Goodnough LT, Shander A: Patient blood management. Anesthesiology 2012; 116:1367-76.
2. Thomas D, Wareham K, Cohen D, Hutchings H: Autologous blood transfusion in total knee replacement surgery. Br J Anaesth 2001; 86:669-73.
3. Shenolikar A, Wareham K, Newington D, Thomas D, Hughes J, Downes M: Cell salvage auto transfusion in total knee replacement surgery. Transfus Med 1997; 7:277-80.
4. Heddle NM, Brox WT, Klama LN, Dickson LL, Levine MN: A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion 1992; 32:742-6.
5. Slagis SV, Benjamin JB, Volz RG, Giordano GF: Postoperative blood salvage in total hip and knee arthroplasty. A randomised controlled trial. J Bone Joint Surg Br 1991; 73:591-4.
6. Huët C, Salmi LR, Fergusson D, Koopman-van-Gemert AW, Rubens F, Laupacis A: A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999; 89:861-9.
7. Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DB, Henderson KM: Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2002:CD002042.
8. Weber EW, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E, van-Os J, Vosmaer A, van-der-Ark P: Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: The European Epoetin Alfa Surgery Trial (EE ST). Eur J Anaesthesiol 2005; 22:249-57.
9. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA: Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2010:CD001888.
10. Warner C: The use of the orthopaedic perioperative autotransfusion (OrthoPAT) system in total joint replacement surgery. Orthop Nurs 2001; 20:29-32.
11. Abuzakuk T, Senthil-Kumar V, Shenava Y, Bulstrode C, Skinner JA, Cannon SR, Briggs TW: Autotransfusion drains in total knee replacement. Are they alternatives to homologous transfusion? Int Orthop 2007; 31:235-9.
12. Adalberth G, Byström S, Kolstad K, Mallmin H, Milbrink J: Postoperative drainage of knee arthroplasty is not necessary: A randomized study of 90 patients. Acta Orthop Scand 1998; 69:475-8.
13. Amin A, Watson A, Mangwani J, Nawabi D, Ahluwalia R, Loeffler M: A prospective randomised controlled trial of autologous retransfusion in total knee replacement. J Bone Joint Surg Br 2008; 90:451-4.
14. Wood GC, Kapoor A, Javed A: Autologous drains in arthroplasty a randomized control trial. J Arthroplasty 2008; 23:808-13.
15. Rollo VJ, Hozack WJ, Rothman RH, Chao W, Eng KO: Prospective randomized evaluation of blood salvage techniques for primary total hip arthroplasty. J Arthroplasty 1995; 10:532-9.
16. So-Osman C, Nelissen RGHH, Koopman-van-Gemert AWMM, Kluyver E, Pöll RG, Onstenk R, Van-Hilten JA, Jansen-Werkhoven TM, Van-den-Hout WB, Brand R, Brand A: Patient blood management in elective total hip- And knee-replacement surgery (part 1): A randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin- eligible patients. Anesthesiology 2014; 120:839-51.
17. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR: Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50:753-65.
18. Zethraeus N, Johannesson M, Jönsson B, Löthgren M, Tambour M: Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003; 21:39-48.
19. Pocock SJ: When (not) to stop a clinical trial for benefit. JAMA 2005; 294:2228-30.
20. Sehat KR, Evans RL, Newman JH: Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 2004; 86:561-5.
21. Waters JH, Dyga RM, Waters JF, Yazer MH: The volume of returned red blood cells in a large blood salvage program: Where does it all go? Transfusion 2011; 51:2126-32.
22. So-Osman C, Nelissen RG, Eikenboom HC, Brand A: Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: A randomized pilot study. Transfus Med 2006; 16:321-8.
23. Vamvakas EC: Rationale for randomized controlled trials and for intention-to-treat analysis in transfusion medicine: Are they one and the same? Vox Sang 2008; 95:165-73.
24. Otten R, van-Roermund PM, Picavet HS: [Trends in the number of knee and hip arthroplasties: Considerably more knee and hip prostheses due to osteoarthritis in 2030]. Ned Tijdschr Geneeskd 2010; 154:A1534.
25. Horstmann WG, Ettema HB, Verheyen CC: Dutch orthopedic blood management surveys 2002 and 2007: An increasing use of blood-saving measures. Arch Orthop Trauma Surg 2009; 30:55-9.